GAMMA Investing LLC Sells 3,869 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• GAMMA Investing LLC has reduced its stake in UnitedHealth Group by 24.4% during the 2nd quarter, now holding shares valued at approximately $3.73 million.
• UBS Group has maintained a buy rating for UnitedHealth Group, while analysts from JPMorgan and Royal Bank of Canada have adjusted their target prices downward.
• UnitedHealth Group recently reported earnings of $4.08 per share, missing estimates, while announcing a quarterly dividend of $2.21 to be paid on September 23rd.

GAMMA Investing LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 24.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The fund owned 11,969 shares of the healthcare conglomerate's stock after selling 3,869 shares during the quarter. GAMMA Investing LLC's holdings in UnitedHealth Group were worth $3,734,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its stake in UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Copia Wealth Management bought a new stake in shares of UnitedHealth Group during the fourth quarter worth about $42,000. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group in the first quarter valued at approximately $42,000. Finally, O Brien Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after buying an additional 37 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 1.4%

UNH stock traded up $4.80 during midday trading on Monday, reaching $341.49. 8,883,715 shares of the company traded hands, compared to its average volume of 13,684,542. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business has a 50 day moving average of $296.49 and a 200-day moving average of $362.50. The firm has a market capitalization of $309.27 billion, a price-to-earnings ratio of 14.80, a P/E/G ratio of 2.20 and a beta of 0.44.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter last year, the company earned $6.80 earnings per share. The company's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio is presently 38.30%.

Analysts Set New Price Targets

UNH has been the subject of a number of analyst reports. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research report on Wednesday, July 30th. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Piper Sandler decreased their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Robert W. Baird restated an "underperform" rating and set a $198.00 price target (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Finally, KeyCorp reduced their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $358.95.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.